MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
- DOI
- 10.1038/s41388-020-01574-8
- Published
- 2021 Jan
- Container
- Oncogene
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41388-020-01574-8,
title = {MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.},
author = {Han J and Qu H and Han M and Ding Y and Xie M and Hu J and Chen Y and Dong H},
year = {2021},
journal = {Oncogene},
doi = {10.1038/s41388-020-01574-8},
url = {https://doi.org/10.1038/s41388-020-01574-8}
}RIS
TY - JOUR TI - MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer. AU - Han J AU - Qu H AU - Han M AU - Ding Y AU - Xie M AU - Hu J AU - Chen Y AU - Dong H PY - 2021 JO - Oncogene DO - 10.1038/s41388-020-01574-8 UR - https://doi.org/10.1038/s41388-020-01574-8 ER -
APA
J, H., H, Q., M, H., Y, D., M, X., J, H., Y, C., & H, D. (2021). MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.. Oncogene. https://doi.org/10.1038/s41388-020-01574-8
Source records
- pubmed · retrieved 2026-09-25T18:38:12.042Z